4.8 Article

eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skipping

期刊

NUCLEIC ACIDS RESEARCH
卷 49, 期 W1, 页码 W193-W198

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkab442

关键词

-

资金

  1. Muscular Dystrophy Canada
  2. Friends of Garrett Cumming Research Fund
  3. HM Toupin Neurological Science Research Fund
  4. Canadian Institutes of Health Research (CIHR)
  5. Alberta Innovates: Health Solutions (AIHS), Jesse's Journey
  6. Women and Children's Health Research Institute (WCHRI)
  7. HOKUSAI BigWaterfall system
  8. Women and Children's Health Research Institute
  9. [2-6]

向作者/读者索取更多资源

Exon skipping using ASOs is a powerful tool for mRNA splicing modulation, but selecting the optimal sequence is difficult. We developed a computational method to design effective ASOs for exon skipping, incorporating machine learning algorithms and experimental data. eSkip-Finder is a web-based resource with a predictor for exon skipping efficacy of ASOs and a database of ASOs.
Exon skipping using antisense oligonucleotides (ASOs) has recently proven to be a powerful tool for mRNA splicing modulation. Several exon-skipping ASOs have been approved to treat genetic diseases worldwide. However, a significant challenge is the difficulty in selecting an optimal sequence for exon skipping. The efficacy of ASOs is often unpredictable, because of the numerous factors involved in exon skipping. To address this gap, we have developed a computational method using machine-learning algorithms that factors in many parameters as well as experimental data to design highly effective ASOs for exon skipping. eSkip-Finder (https://eskip-finder.org) is the first web-based resource for helping researchers identify effective exon skipping ASOs. eSkip-Finder features two sections: (i) a predictor of the exon skipping efficacy of novel ASOs and (ii) a database of exon skipping ASOs. The predictor facilitates rapid analysis of a given set of exon/intron sequences and ASO lengths to identify effective ASOs for exon skipping based on a machine learning model trained by experimental data. We confirmed that predictions correlated well with in vitro skipping efficacy of sequences that were not included in the training data. The database enables users to search for ASOs using queries such as gene name, species, and exon number.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据